Apollo Hospitals Enterprise Ltd. is Rated Hold

Mar 09 2026 10:10 AM IST
share
Share Via
Apollo Hospitals Enterprise Ltd. is rated 'Hold' by MarketsMojo, with this rating last updated on 09 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook.
Apollo Hospitals Enterprise Ltd. is Rated Hold

Current Rating and Its Significance

The 'Hold' rating assigned to Apollo Hospitals Enterprise Ltd. indicates a balanced view of the stock’s prospects. It suggests that while the company demonstrates solid fundamentals and growth potential, certain factors advise caution for investors considering new positions or expecting significant near-term gains. This rating serves as a signal for investors to maintain their existing holdings rather than aggressively buying or selling at this stage.

Quality Assessment

As of 09 March 2026, Apollo Hospitals maintains a strong quality profile. The company boasts a high Return on Capital Employed (ROCE) of 16.84%, reflecting efficient use of capital to generate profits. This level of management efficiency is a key indicator of sustainable operational performance. Additionally, Apollo Hospitals has demonstrated consistent positive results over the last nine consecutive quarters, underscoring its resilience and steady growth trajectory in the hospital sector.

Valuation Perspective

The stock’s valuation remains attractive relative to its peers. Currently, Apollo Hospitals trades at an Enterprise Value to Capital Employed ratio of 8.3, which is considered reasonable given its growth prospects. The company’s PEG ratio stands at 1.6, indicating that its price is fairly aligned with its earnings growth rate. Moreover, the stock is trading at a discount compared to the average historical valuations of its sector peers, offering a value proposition for investors mindful of price levels.

Financial Trend Analysis

The latest data shows a positive financial trend for Apollo Hospitals. Net sales have grown at an annual rate of 17.93%, while operating profit has surged by 39.35%, signalling robust top-line and bottom-line expansion. The company’s ability to service debt is strong, with a low Debt to EBITDA ratio of 1.48 times, reducing financial risk. Institutional investors hold a significant 65.27% stake, reflecting confidence from knowledgeable market participants who typically conduct thorough fundamental analysis.

Technical Outlook

From a technical standpoint, the stock is currently exhibiting sideways movement. This suggests a period of consolidation where price fluctuations are relatively contained without a clear directional trend. Such a pattern often precedes a significant move but requires investors to exercise patience and monitor for breakout signals before making decisive trading decisions.

Performance and Market Position

As of 09 March 2026, Apollo Hospitals has delivered a one-year return of 22.57%, outperforming many peers in the hospital sector. Year-to-date, the stock has gained 8.19%, with a three-month return of 7.46%. Despite a slight decline over six months (-2.82%), the overall performance remains positive. The company’s market capitalisation stands at ₹1,11,123 crores, making it the largest entity in its sector and representing 20.03% of the entire hospital industry market cap. Its annual sales of ₹24,215.20 crores account for 28.50% of the sector’s total, highlighting its dominant market position.

Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!

  • - Recently turned profitable
  • - Strong business fundamentals
  • - Pre-breakout opportunity

Catch the Breakout Early →

Implications for Investors

Investors should interpret the 'Hold' rating as a signal to maintain their current positions while closely monitoring the company’s developments. The strong quality and financial trends provide reassurance of Apollo Hospitals’ operational strength and growth potential. However, the sideways technical trend and valuation considerations suggest that the stock may not offer immediate upside momentum. This balanced outlook encourages a cautious approach, favouring steady accumulation over speculative trading.

Sector Leadership and Industry Context

Apollo Hospitals’ leadership in the hospital sector is evident not only in its market capitalisation but also in its contribution to industry sales. Constituting nearly a fifth of the sector’s market cap and over a quarter of its sales, the company plays a pivotal role in shaping sector dynamics. Its consistent financial performance and attractive valuation relative to peers make it a benchmark stock within the healthcare space.

Summary of Key Metrics as of 09 March 2026

To summarise, Apollo Hospitals Enterprise Ltd. exhibits the following key metrics:

  • Mojo Score: 61.0 (Hold grade)
  • ROCE: 16.84%
  • Debt to EBITDA: 1.48 times
  • Net Sales Growth (Annual): 17.93%
  • Operating Profit Growth: 39.35%
  • Market Capitalisation: ₹1,11,123 crores
  • Institutional Holdings: 65.27%
  • One-Year Return: +22.57%

These figures collectively underpin the 'Hold' rating, reflecting a company with solid fundamentals and growth prospects, yet currently in a phase of price consolidation and valuation moderation.

Conclusion

Apollo Hospitals Enterprise Ltd.’s current 'Hold' rating by MarketsMOJO, updated on 09 January 2026, is supported by a comprehensive evaluation of quality, valuation, financial trends, and technical factors as of 09 March 2026. For investors, this rating suggests maintaining existing holdings while observing market developments and company performance for future opportunities. The stock’s strong fundamentals and sector leadership provide a foundation for long-term value, even as short-term price movements remain cautious.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News